Pharmacy
Interoperability and workflow norms stand in the way, but convincing insurers the tech is worth the extra price tag can be the biggest obstacle.
Several companies are working with policymakers and other vendors to reduce overprescribing.
The legendary singer claims Soon-Shiong and other Altor board members hid the success of a promising cancer and AIDS/HIV drug.
The partnership offers users of Enclara’s E3 Mobile order management system integrated access to pharmacy services and durable medical equipment management.
RxMatch, a new service for Intermountain care providers, allows physicians to use patients’ genomics to find the right antidepressant faster than using existing trial-and-error methods.
Truveris, which serves the prescription benefits industry said the Series D funding round, led by McKesson Ventures, will help lower cost and boost access to prescription medications.
The Every Prescription Conveyed Securely Act, filed in the U.S. House of Representatives, would mandate e-prescribing for controlled substances under Medicare Part D.
Electronic prescribing of controlled substances was up 256 percent in 2016, company says.
Brett Giroir, who is currently CEO of biopharmaceutical company ViraCyte, takes over role formerly held by Karen DeSalvo.
The reversal of opinion could now open the floodgates for other genetic testing companies.